Evidence map›Paper›PMID 41838920›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Pharmaco-behavioral profiling identifies suppressors of autism gene-associated phenotypes in zebrafish.

Priyanka Jamadagni, Yi Dai, Yunqing Liu, Hellen Weinschutz Mendes, April Pruitt, Suha Khan, Liang Yang, Tzu-Chieh Huang, Xiayuan Huang, P J Michael Deans and 18 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Priyanka Jamadagni *Child Study Center, Yale School of Medicine, New Haven, CT 06510.
Yi Dai *Department of Biostatistics, Yale School of Public Health, New Haven, CT 06510.
Yunqing Liu *Department of Biostatistics, Yale School of Public Health, New Haven, CT 06510.
Hellen Weinschutz Mendes *Child Study Center, Yale School of Medicine, New Haven, CT 06510.ORCID 0000-0002-4282-6498
April Pruitt *Child Study Center, Yale School of Medicine, New Haven, CT 06510.ORCID 0000-0002-5807-5422
Suha Khan *Child Study Center, Yale School of Medicine, New Haven, CT 06510.
Liang Yang *Department of Psychiatry, Division of Molecular Psychiatry, Yale University School of Medicine, New Haven, CT 06511.
Tzu-Chieh Huang *Department of Psychiatry, Division of Molecular Psychiatry, Yale University School of Medicine, New Haven, CT 06511.
Xiayuan Huang *Department of Biostatistics, Yale School of Public Health, New Haven, CT 06510.ORCID 0000-0002-3730-5014
P J Michael DeansDepartment of Psychiatry, Division of Molecular Psychiatry, Yale University School of Medicine, New Haven, CT 06511.
Novin BalafkanDepartment of Psychiatry, Division of Molecular Psychiatry, Yale University School of Medicine, New Haven, CT 06511.
Dejian ZhaoDepartment of Genetics, Yale School of Medicine, New Haven, CT 06510.ORCID 0000-0002-2105-3799
Gang XuDepartment of Biostatistics, Yale School of Public Health, New Haven, CT 06510.ORCID 0009-0005-2974-0840
Yihan LiuDepartment of Biostatistics, Yale School of Public Health, New Haven, CT 06510.ORCID 0009-0003-0386-9908
Ningshan LiDepartment of Biostatistics, Yale School of Public Health, New Haven, CT 06510.ORCID 0000-0003-1916-2563
Weimiao WuDepartment of Biostatistics, Yale School of Public Health, New Haven, CT 06510.
Sarah E FitzpatrickChild Study Center, Yale School of Medicine, New Haven, CT 06510.ORCID 0000-0001-7446-6469
Uma NeelakantanChild Study Center, Yale School of Medicine, New Haven, CT 06510.
Tianying ChenChild Study Center, Yale School of Medicine, New Haven, CT 06510.
Christina SzialtaChild Study Center, Yale School of Medicine, New Haven, CT 06510.
David S JinDepartment of Neuroscience, Yale School of Medicine, New Haven, CT 06510.
Cheryl M LacadieDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT 06510.
Sheila UmlaufYale Center for Molecular Discovery, Yale School of Medicine, New Haven, CT 06510.ORCID 0000-0002-8671-7744
Xenophon PapademetrisDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT 06510.
Yulia V SurovtsevaYale Center for Molecular Discovery, Yale School of Medicine, New Haven, CT 06510.
Kristen J BrennandDepartment of Psychiatry, Division of Molecular Psychiatry, Yale University School of Medicine, New Haven, CT 06511.ORCID 0000-0003-0993-5956
Zuoheng Wang *Department of Biostatistics, Yale School of Public Health, New Haven, CT 06510.ORCID 0000-0002-7251-3687
Ellen J Hoffman *Child Study Center, Yale School of Medicine, New Haven, CT 06510.ORCID 0000-0002-5083-1369

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007205 · NIGMS · YALE UNIVERSITY · PI KAZMIERCZAK, BARBARA I · 1985 to 2019
$42.9M
High-throughput in vivo and in vitro functional and multi-omics screens of neuropsychiatric and neurodevelopmental disorder risk genesRM1MH132648 · NIMH · YALE UNIVERSITY · PI Kristen Jennifer Brennand, Rong Fan · 2023 to 2026
$5.6M
High-throughput Functional Analysis of Autism Risk GenesR01MH116002 · NIMH · YALE UNIVERSITY · PI ELLEN J HOFFMAN · 2018 to 2026
$4.5M
Investigating the Translatome in Genetic Models of AutismR21MH133245 · NIMH · YALE UNIVERSITY · PI HOFFMAN, ELLEN J · 2023 to 2024
$459k
The Role of the ASD Risk Gene CHD8 in Neural DevelopmentF30MH132282 · NIMH · YALE UNIVERSITY · PI FITZPATRICK, SARAH E. · 2022 to 2025
$153k
Autism Science Foundation (ASF) 22-005HHS | National Institutes of Health (NIH) T32GM007205HHS | NIH | National Institute of Mental Health (NIMH) F30MH132282HHS | NIH | National Institute of Mental Health (NIMH) R01MH116002HHS | NIH | National Institute of Mental Health (NIMH) R21MH133245HHS | NIH | National Institute of Mental Health (NIMH) RM1MH132648Howard Hughes Medical Institute (HHMI) Gilliam Fellowship (GT16695)Interdepartmental Neuroscience Program at Yale N/AKavli Foundation (Kavli) N/ANational Genetics Foundation N/ASimons Foundation Autism Research Initiative (SFARI) 34599Simons Foundation Autism Research Initiative (SFARI) 573508Spector Fund N/ASwebilius Foundation N/AUnited States - Israel Binational Science Foundation (BSF) 2017325
6 · The paper itself

Abstract

Pharmaco-behavioral screens in scalable in vivo systems have critical advantages for drug discovery relevant to large-effect autism spectrum disorder (ASD) genes. Here, we establish a database and open-source website of the behavioral signatures of 520 US Food and Drug Administration (FDA)-approved drugs using high-throughput assays of basic sensory processing and arousal behaviors in larval zebrafish. By leveraging the behavioral profiles of 9 large-effect ASD gene mutants, we identify enrichment of pharmacological mechanisms that anticorrelate with subgroups of ASD genes with shared behavioral phenotypes. Screening of anticorrelating drugs in mutants of two ASD genes,

Indexed as

Autism Spectrum DisorderAutistic DisorderBehavior, AnimalAnimalsDisease Models, AnimalDrug DiscoveryDyrk KinasesHumansMutationPaclitaxelPhenotypeProtein Serine-Threonine KinasesProtein-Tyrosine KinasesZebrafishZebrafish ProteinsDyrk KinasesPaclitaxelProtein Serine-Threonine KinasesProtein-Tyrosine KinasesZebrafish Proteinsautism spectrum disordergeneticshigh-throughputpharmacological screenzebrafish

Identifiers

PMID41838920
PMCPMC13012064

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.